{"id":"NCT00213135","sponsor":"EMD Serono","briefTitle":"A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)","officialTitle":"A Phase III, Randomized, Double-blind, Three-arm, Placebo-controlled, Multi-center Study to Evaluate the Safety and Efficacy of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-04","primaryCompletion":"2008-11","completion":"2008-11","firstPosted":"2005-09-21","resultsPosted":"2013-12-02","lastUpdate":"2014-02-07"},"enrollment":1326,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Sclerosis, Relapsing-Remitting"],"interventions":[{"type":"DRUG","name":"Cladribine 5.25 mg/kg","otherNames":[]},{"type":"DRUG","name":"Cladribine 3.5 mg/kg","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Cladribine 5.25 mg/kg","type":"EXPERIMENTAL"},{"label":"Cladribine 3.5 mg/kg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to determine if cladribine tablets are a safe and effective treatment for relapsing-remitting multiple sclerosis (RRMS).","primaryOutcome":{"measure":"Annualized Qualifying Relapse Rate","timeFrame":"Week 96","effectByArm":[{"arm":"Cladribine 5.25 mg/kg","deltaMin":0.15,"sd":0.58},{"arm":"Cladribine 3.5 mg/kg","deltaMin":0.14,"sd":0.59},{"arm":"Placebo","deltaMin":0.33,"sd":0.88}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":15},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20089960","36017797","36017780","35920065","35019731","35003076","34370275","33969750","32447743","29992396","28817997","28255849","28140753","22017519"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":41,"n":454},"commonTop":["Headache","Lymphopenia","Nasopharyngitis","Upper respiratory tract infection","Nausea"]}}